AMRX Operating Cash Flow (Statement)
Amneal Pharmaceuticals Inc Class A · Operating Cash Flow (Statement)
AMRX Operating Cash Flow (Statement)
Latest reported$200.78Mperiod ending
AMRX Cash from Operations ($112.26M → $200.78M)
Annual operating cash flow (statement)
High-resolution chart · PNG
AMRX operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 339,992,000 | |
| 295,099,000 | |
| 345,577,000 | |
| 65,100,000 | |
| 241,820,000 | |
| 379,001,000 | |
| 1,705,000 | |
| 250,230,000 | |
| 234,187,000 | |
| 115,060,000 | |
| 104,883,000 | |
| 112,257,000 |